机构持仓方面，截止2025年9月30日，安井食品十大流通股东中，香港中央结算有限公司位居第四大流 通股东，持股540.10万股，相比上期减少653.91万股。中庚价值先锋股票（012930）位居第八大流通股 东，持股430.55万股，相比上期减少11.35万股。南方中证500ETF（510500）退出十大流通股东之列。 资料显示，安井食品集团股份有限公司位于福建省厦门市海沧区新阳路2508号,香港湾仔皇后大道东183 号合和中心46楼，成立日期2001年12月24日，上市日期2017年2月22日，公司主营业务涉及安井食品集 团股份有限公司（原名：福建安井食品股份有限公司）是一家主要从事速冻食品的研发、生产和销售的 中国公司。该公司的速冻调制食品主要包括鱼豆腐、鱼丸、撒尿肉丸及烤肠等。速冻菜肴制品主要包括 小龙虾、小酥肉、虾滑、牛肉卷、羊肉卷、蛋饺及酸菜鱼等。速冻面米制品主要包括烧麦、奶香馒头、 手抓饼及红糖发糕等。其他产品主要包括鱼糜、鱼粉及其他鱼类副产品。该公司主要在中国国内和海外 市场开展业务。主营业务收入构成为：速冻调制食品49.43%，速冻菜肴制品31.77%，速冻面米制品 16.32%，农副产品及其 ...

分红方面，泰格医药A股上市后累计派现24.58亿元。近三年，累计派现11.54亿元。 机构持仓方面，截止2025年9月30日，泰格医药十大流通股东中，香港中央结算有限公司位居第二大流 通股东，持股4836.25万股，相比上期增加2509.69万股。中欧医疗健康混合A（003095）位居第四大流 通股东，持股2885.17万股，相比上期增加121.78万股。华宝中证医疗ETF（512170）位居第五大流通股 东，持股1456.80万股，相比上期减少266.25万股。易方达创业板ETF（159915）位居第八大流通股东， 持股1125.86万股，相比上期减少188.83万股。华泰柏瑞沪深300ETF（510300）位居第十大流通股东， 持股877.79万股，为新进股东。兴全商业模式混合(LOF)A（163415）退出十大流通股东之列。 责任编辑：小浪快报 资料显示，杭州泰格医药科技股份有限公司位于浙江省杭州市滨江区西兴街道聚工路19号盛大科技园A 座18层，成立日期2004年12月15日，上市日期2012年8月17日，公司主营业务涉及为国内外医药及健康 相关产品的研究开发提供专业临床研究服务,业务范围主要包括I至 ...

鸿合科技所属申万行业为：电子-光学光电子-面板。所属概念板块包括：社保重仓、华为概念、物联 网、手势识别、托育概念等。 1月13日，鸿合科技盘中下跌2.02%，截至14:09，报29.62元/股，成交1.20亿元，换手率2.04%，总市值 70.09亿元。 资金流向方面，主力资金净流出1112.58万元，特大单买入221.48万元，占比1.84%，卖出641.42万元， 占比5.34%；大单买入1830.45万元，占比15.24%，卖出2523.09万元，占比21.01%。 鸿合科技今年以来股价跌2.15%，近5个交易日跌1.66%，近20日跌0.60%，近60日涨15.25%。 资料显示，鸿合科技股份有限公司位于北京市朝阳区北辰东路8号院北辰时代大厦9层，成立日期2010年 5月28日，上市日期2019年5月23日，公司主营业务涉及智能交互显示产品及智能视听解决方案的设计、 研发、生产与销售。主营业务收入构成为：IWB产品73.68%，其他智能交互产品18.91%，智能视听解 决方案7.42%。 截至1月9日，鸿合科技股东户数1.69万，较上期减少1.46%；人均流通股11647股，较上期增加1.48%。 ...

1月13日，立华股份盘中下跌2.04%，截至14:06，报20.67元/股，成交1.55亿元，换手率1.18%，总市值 173.06亿元。 机构持仓方面，截止2025年9月30日，立华股份十大流通股东中，国泰中证畜牧养殖ETF（159865）位 居第十大流通股东，持股746.03万股，为新进股东。易方达创业板ETF（159915）退出十大流通股东之 列。 资金流向方面，主力资金净流出1136.89万元，特大单买入476.05万元，占比3.07%，卖出291.00万元， 占比1.88%；大单买入1874.62万元，占比12.09%，卖出3196.56万元，占比20.62%。 立华股份今年以来股价跌0.39%，近5个交易日跌0.67%，近20日涨1.52%，近60日跌7.06%。 责任编辑：小浪快报 资料显示，江苏立华食品集团股份有限公司位于江苏省常州市武进区牛塘镇漕溪路66号，成立日期1997 年6月19日，上市日期2019年2月18日，公司主营业务涉及黄羽鸡、生猪、肉鹅的生产与销售。主营业务 收入构成为：鸡收入75.84%，猪23.31%，鹅0.86%。 立华股份所属申万行业为：农林牧渔-养殖业-肉鸡养殖。所 ...

Group 1 - The core viewpoint of the news is that Anjuke Food's stock has experienced fluctuations, with a recent decline of 2.00% and a total market capitalization of 28.73 billion yuan [1] - As of January 13, Anjuke Food's stock price is 86.20 yuan per share, with a trading volume of 347 million yuan and a turnover rate of 1.36% [1] - Year-to-date, Anjuke Food's stock has increased by 8.73%, with a 4.19% rise over the last five trading days, an 8.59% increase over the last 20 days, and a 22.83% increase over the last 60 days [1] Group 2 - Anjuke Food Group Co., Ltd. is based in Xiamen, Fujian Province, and was established on December 24, 2001, with its listing date on February 22, 2017 [2] - The company specializes in the research, production, and sales of frozen foods, including products like fish tofu, fish balls, and various frozen dishes [2] - The revenue composition of Anjuke Food includes 49.43% from frozen prepared foods, 31.77% from frozen dishes, 16.32% from frozen noodle and rice products, and 2.38% from agricultural products and others [2] Group 3 - As of September 30, Anjuke Food had 63,200 shareholders, an increase of 78.56% from the previous period, with an average of 4,641 circulating shares per shareholder, a decrease of 43.98% [3] - For the period from January to September 2025, Anjuke Food achieved a revenue of 11.371 billion yuan, a year-on-year increase of 2.66%, while the net profit attributable to shareholders decreased by 9.35% to 949 million yuan [3] Group 4 - Anjuke Food has distributed a total of 3.219 billion yuan in dividends since its A-share listing, with 2.521 billion yuan distributed in the last three years [4] - As of September 30, 2025, the largest circulating shareholder is Hong Kong Central Clearing Limited, holding 5.401 million shares, a decrease of 6.5391 million shares from the previous period [4] - The Southern CSI 500 ETF has exited the list of the top ten circulating shareholders [4]

Core Viewpoint - The stock price of Sanyou Chemical has shown a positive trend, with a year-to-date increase of 9.05% and significant gains over various trading periods, indicating strong market interest and potential growth in the company's performance [1]. Group 1: Stock Performance - As of January 13, Sanyou Chemical's stock price rose by 2.27% to 6.75 CNY per share, with a trading volume of 2.09 billion CNY and a turnover rate of 1.54%, resulting in a total market capitalization of 139.34 billion CNY [1]. - The stock has increased by 3.05% over the last five trading days, 16.98% over the last 20 days, and 23.40% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Sanyou Chemical reported a revenue of 14.164 billion CNY, a year-on-year decrease of 11.90%, and a net profit attributable to shareholders of 122 million CNY, down 69.18% year-on-year [2]. - The company has distributed a total of 4.376 billion CNY in dividends since its A-share listing, with 623 million CNY distributed over the last three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Sanyou Chemical was 72,100, a decrease of 17.30% from the previous period, with an average of 28,626 circulating shares per shareholder, an increase of 20.92% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 37.0345 million shares, an increase of 5.6333 million shares from the previous period, and new shareholders such as Guangfa Advantage Growth Stock A and Guangfa Jufeng Mixed A [3].

久立特材所属申万行业为：钢铁-特钢Ⅱ-特钢Ⅲ。所属概念板块包括：特种钢、油气管网、养老金概 念、核聚变、社保重仓等。 截至9月30日，久立特材股东户数2.76万，较上期增加34.16%；人均流通股34604股，较上期减少 25.46%。2025年1月-9月，久立特材实现营业收入97.47亿元，同比增长36.45%；归母净利润12.62亿元， 同比增长20.73%。 1月13日，久立特材盘中下跌2.00%，截至09:54，报29.33元/股，成交1.14亿元，换手率0.40%，总市值 286.60亿元。 资金流向方面，主力资金净流出907.71万元，特大单买入130.68万元，占比1.15%，卖出636.25万元，占 比5.60%；大单买入2423.66万元，占比21.32%，卖出2825.79万元，占比24.86%。 久立特材今年以来股价涨1.31%，近5个交易日涨1.17%，近20日涨13.42%，近60日涨18.46%。 资料显示，浙江久立特材科技股份有限公司位于浙江省湖州市吴兴区中兴大道1899号，成立日期2004年 1月8日，上市日期2009年12月11日，公司主营业务涉及工业用不锈钢管及特种合金的管 ...

Group 1 - The core viewpoint of the news is that Xilinmen's stock has shown fluctuations in price and trading volume, with a recent increase of 2.02% and a total market capitalization of 7.631 billion yuan [1] - As of January 12, Xilinmen's stock price is 20.72 yuan per share, with a trading volume of 256 million yuan and a turnover rate of 3.43% [1] - Year-to-date, Xilinmen's stock has increased by 1.17%, but has seen a decline of 7.21% over the last five trading days and 9.48% over the last twenty days [1] Group 2 - Xilinmen Furniture Co., Ltd. was established on November 6, 1996, and went public on July 17, 2012, focusing on the research, production, and sales of mattresses, soft beds, and hotel furniture [2] - The company's main business revenue composition includes mattresses (60.37%), soft beds and accessories (27.93%), sofas (8.24%), wooden furniture (1.91%), and others (1.55%) [2] - As of October 31, the number of shareholders in Xilinmen is 16,000, with an average of 23,049 circulating shares per person, a decrease of 0.85% from the previous period [2] Group 3 - Xilinmen has distributed a total of 905 million yuan in dividends since its A-share listing, with 517 million yuan distributed in the last three years [3] - As of September 30, 2025, Hong Kong Central Clearing Limited is the third-largest circulating shareholder, holding 12.3172 million shares as a new shareholder [3] - The sixth-largest circulating shareholder is the招商量化精选股票发起式A (001917), holding 5.0963 million shares, also as a new shareholder [3]

1月9日，恩华药业盘中上涨2.03%，截至14:04，报24.64元/股，成交2.72亿元，换手率1.27%，总市值 250.29亿元。 资金流向方面，主力资金净流出1150.83万元，特大单买入1082.59万元，占比3.98%，卖出2785.73万 元，占比10.24%；大单买入6242.31万元，占比22.96%，卖出5690.00万元，占比20.92%。 恩华药业今年以来股价涨2.11%，近5个交易日涨2.11%，近20日涨0.53%，近60日跌5.16%。 资料显示，江苏恩华药业股份有限公司位于江苏省徐州市经济技术开发区龙湖西路31号恩华科技大厦， 成立日期1999年3月29日，上市日期2008年7月23日，公司主营业务涉及医药生产、研发和销售,医药销 售含公司生产的制剂销售及医药批发和零售业务。主营业务收入构成为：麻醉类54.28%，精神类 20.63%，商业医药13.08%，神经类5.51%，原料药2.98%，其他销售2.41%，其他贸易及劳务(注 1)0.58%，其他(补充)0.52%。 截至9月30日，恩华药业股东户数3.74万，较上期减少14.20%；人均流通股23614股，较上期增加 1 ...

Core Viewpoint - Huafeng Chemical's stock has shown significant growth in recent trading sessions, with a notable increase in both price and trading volume, indicating strong market interest and potential investment opportunities [1][2]. Group 1: Stock Performance - As of January 9, Huafeng Chemical's stock price increased by 2.04%, reaching 11.98 CNY per share, with a trading volume of 311 million CNY and a turnover rate of 0.53%, resulting in a total market capitalization of 59.451 billion CNY [1]. - Year-to-date, the stock price has risen by 8.91%, with a 31.36% increase over the past 20 days and a 37.39% increase over the past 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Huafeng Chemical reported a revenue of 18.109 billion CNY, reflecting a year-on-year decrease of 11.11%, while the net profit attributable to shareholders was 1.462 billion CNY, down 27.45% year-on-year [2]. - Cumulatively, the company has distributed 5.124 billion CNY in dividends since its A-share listing, with 2.481 billion CNY distributed over the past three years [3]. Group 3: Shareholder Structure - As of September 30, 2025, the number of shareholders for Huafeng Chemical decreased by 25.68% to 48,400, while the average number of tradable shares per shareholder increased by 34.55% to 102,258 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 72.5173 million shares, an increase of 3.3948 million shares from the previous period, while the Southern CSI 500 ETF reduced its holdings by 562,700 shares [3].